Published in J Gastroenterol on March 18, 2014
IgG4-related autoimmune diseases: Polymorphous presentation complicates diagnosis and treatment. Dtsch Arztebl Int (2015) 1.70
IgG4-related kidney disease--an update. Curr Opin Nephrol Hypertens (2015) 1.11
IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag (2016) 0.93
IgG4-Related Disease: Results From a Multicenter Spanish Registry. Medicine (Baltimore) (2015) 0.92
Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Clin Exp Nephrol (2015) 0.81
Severe IgG4-Related Disease in a Young Child: A Diagnosis Challenge. Case Rep Pediatr (2015) 0.81
Diagnosis and Treatment of Autoimmune Pancreatitis in China: A Systematic Review. PLoS One (2015) 0.79
From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis. Gastroenterol Res Pract (2017) 0.75
Long-term outcomes of autoimmune pancreatitis. World J Gastroenterol (2016) 0.75
An overview of the diagnosis and management of immunoglobulin G4-related disease. CMAJ (2016) 0.75
Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: A case report and literature review. Medicine (Baltimore) (2017) 0.75
Outcome and Genetic Factors in IgG4-Associated Autoimmune Pancreatitis and Cholangitis: A Single Center Experience. Gastroenterol Res Pract (2017) 0.75
Autoimmune pancreatitis. Gland Surg (2016) 0.75
Neurological Manifestations of IgG4-Related Disease. Curr Treat Options Neurol (2017) 0.75
Treatment of IgG4-related disease : Current and future approaches. Z Rheumatol (2016) 0.75
Diagnosis and Management of Autoimmune Pancreatitis. Curr Treat Options Gastroenterol (2017) 0.75
[A 70-year-old patient with painful exophthalmos and double vision]. Ophthalmologe (2016) 0.75
Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients. J Gastroenterol (2017) 0.75
Clinical features of IgG4-related periaortitis/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study. Arthritis Res Ther (2017) 0.75
Non-MalIg(G4)nant Biliary Obstruction: When the Pill Is Mightier than the Knife. Dig Dis Sci (2014) 0.75
Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med (1993) 7.67
Autoimmune pancreatitis. N Engl J Med (2006) 5.00
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33
Standard steroid treatment for autoimmune pancreatitis. Gut (2009) 4.33
Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol (2006) 3.40
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol (2006) 3.04
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum (2010) 2.90
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol (2010) 2.25
Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc (2007) 2.23
Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol (2004) 2.06
Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol (2009) 2.04
Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas (2003) 1.96
Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology (2010) 1.86
Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology (2007) 1.82
Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol (2009) 1.70
Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol (2009) 1.56
Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy. Intern Med (2009) 1.54
Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology (2005) 1.46
Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut (2007) 1.43
Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol (2008) 1.35
Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol (2004) 1.32
Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas (2006) 1.26
A case of pancreas cancer with autoimmune pancreatitis. Pancreas (2006) 1.26
Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol (2008) 1.24
Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas (2003) 1.14
Is autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas (2007) 1.13
Clinical significance of extrapancreatic lesions in autoimmune pancreatitis. Pancreas (2010) 1.12
Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterol (2008) 1.10
Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet (2000) 1.09
Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment. Pancreas (2005) 1.06
Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study. Pancreas (2008) 1.05
Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol (2007) 1.04
Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol (2009) 1.03
Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med (2008) 1.03
Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas (2009) 1.02
Optimising corticosteroid treatment for autoimmune pancreatitis. Gut (2007) 1.01
Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med (2006) 1.00
Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitis. Pancreatology (2005) 0.92
Prognosis of autoimmune pancreatitis. J Gastroenterol (2007) 0.92
Long-term outcome of autoimmune pancreatitis. J Gastroenterol (2009) 0.91
Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology (2008) 0.90
Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas (2007) 0.90
Diagnosis and management of autoimmune pancreatitis: experience from China. World J Gastroenterol (2008) 0.88
Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int (2009) 0.85
Autoimmune pancreatitis: a report from India. JOP (2010) 0.78
Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. Am J Gastroenterol (2007) 0.77
A case of pancreatic carcinoma with suspected autoimmune pancreatitis. Clin J Gastroenterol (2008) 0.77
Natural course of autoimmune pancreatitis without steroid therapy showing hypoechoic masses in the uncinate process and tail of the pancreas on ultrasonography. J Ultrasound Med (2006) 0.76
Chronic pancreatitis with synchronous and metachronous malignancy: three unusual cases and a literature review. J Surg Educ (2007) 0.75
Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.55
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol (2012) 7.39
Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg (2012) 5.55
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab (2006) 3.34
Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol (2013) 3.26
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol (2006) 3.04
Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology (2002) 2.71
Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet (2002) 2.69
Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol (2007) 2.60
Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol (2011) 2.59
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity (2012) 2.47
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology (2007) 2.42
Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res (2004) 2.42
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther (2009) 2.41
IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int (2010) 2.39
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol (2007) 2.33
Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol (2008) 2.31
Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol (2014) 2.30
Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut (2010) 2.29
Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol (2004) 2.27
A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet (2009) 2.26
Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS One (2013) 2.26
Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol (2010) 2.25
Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis (2012) 2.25
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol (2010) 2.18
The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol (2004) 2.14
Japanese clinical guidelines for autoimmune pancreatitis. Pancreas (2009) 2.11
How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations? J Thorac Oncol (2013) 2.11
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology (2009) 2.11
Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet (2013) 2.10
Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunol Immunother (2009) 2.10
Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep (2011) 2.09
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery (2011) 2.06
MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res (2011) 2.01
Mechanisms of lower bile duct stricture in autoimmune pancreatitis. Pancreas (2014) 1.98
Time-dependent regional myocardial denervation as a nonspecific response to transmyocardial laser revascularization. Ann Thorac Surg (2005) 1.98
Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas (2003) 1.96
alpha-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma. Pancreas (2010) 1.94
Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol (2007) 1.87
Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc (2005) 1.81
Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res (2005) 1.77
Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas (2004) 1.76
Mutations in the serine protease inhibitor Kazal Type 1 (SPINK1) gene in Japanese patients with pancreatitis. Pancreatology (2005) 1.74
Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci (2012) 1.72
Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology (2002) 1.72
Physical activity and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci (2006) 1.72
Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis. Am J Surg Pathol (2004) 1.67
Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology (2002) 1.67
Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol (2008) 1.67
Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology (2003) 1.66
Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis. Am J Surg Pathol (2005) 1.66
A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol (2010) 1.66